Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Personal Finance Center Mortgages Loans Investing & Retirement Spending & Savings

Calculators

401k Retirement Calculator Mortgage Calculator

Compound Interest Calculator Dollar Cost Averaging

Student Loan Calculator Auto Loan Calculator

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks TipRanks Community Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

Follow Us

TOOLS

Earnings Calendar

Daily Analyst Ratings

STOCKS

ADVANCED RESEARCH

TipRanks Premium

Invest Like a Pro with Unique Data & Simplifed ToolsTry Now

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

TipRanks Community

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Follow Us

Design Therapeutics (DSGN)

NASDAQ:DSGN

US Market

DSGN

Design Therapeutics

Analyst Forecasts

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Design Therapeutics (DSGN) Stock News & Sentiment

68 Followers

Design Therapeutics, Inc.: Navigating Liquidity Risks Amidst Bank Failures

PremiumCompany Announcements

Design Therapeutics, Inc.: Navigating Liquidity Risks Amidst Bank Failures

1M ago

Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results

PremiumPress Releases

Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results

1M ago

Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update

PremiumPress Releases

Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update

2M ago

Design Therapeutics, Inc. (DSGN) Q4 Earnings Cheat Sheet

PremiumPre-Earnings

Design Therapeutics, Inc. (DSGN) Q4 Earnings Cheat Sheet

2M ago

Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024

PremiumPress Releases

Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024

5M ago

Multiple Downgrades Send Design Therapeutics (NASDAQ:DSGN) Down in Flames

PremiumMarket News

Multiple Downgrades Send Design Therapeutics (NASDAQ:DSGN) Down in Flames

8M ago

Design Therapeutics Reports Initial Results from Phase 1 Multiple-Ascending Dose Study of DT-216 for the Treatment of Friedrich Ataxia

PremiumPress Releases

Design Therapeutics Reports Initial Results from Phase 1 Multiple-Ascending Dose Study of DT-216 for the Treatment of Friedrich Ataxia

9M ago

More DSGN News >

DSGN News on the Web

2024-03-27

Independent Director of Design Therapeutics Picks Up 88% More Stock

Yahoo Finance

Neutral

2024-03-23

Companies Like Design Therapeutics Are In A Position To Invest In Growth

Yahoo Finance

Neutral

2024-03-20

Design Therapeutics, Inc. Q4 2023 Earnings Call Transcript

Yahoo Finance

Bullish

2024-03-20

Analysts Conflicted on These Healthcare Names: Diamedica Therapeutics (DMAC), Design Therapeutics (DSGN) and MiMedx Group (MDXG)

TipRanks News

Neutral

2024-03-20

DSGN Stock Earnings: Design Therapeutics Beats EPS for Q4 2023

InvestorPlace

Neutral

2024-03-19

Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results

Yahoo Finance

Neutral

2024-03-12

Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update

Yahoo Finance

Neutral

2023-12-18

Design Therapeutics, Inc. Upgraded to Buy: Here's What You Should Know

Yahoo Finance

Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DSGN’s Media Buzz Sentiment?

Currently, no data Available

What is DSGN’s weekly average amount of articles?

Currently, no data Available

What is DSGN’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

IMVTImmunovant

RVVRevive Therapeutics

NVSNovartis

ISRGIntuitive Surgical

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing